NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Genotyping of DNA samples isolated from formalin-fixed paraffin-embedded tissues using preamplification.

Author(s): Baak-Pablo R, Dezentje V, Guchelaar HJ, van der Straaten T

Publication: J Mol Diagn, 2010, Vol. 12, Page 746-9

PubMed ID: 20847277 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine if preamplification of DNA allows for accurate genotype determination from formalin-fixed paraffin-embedded (FFPE) breast carcinoma specimens.

Conclusion of Paper

In non-preamplified FFPE specimens, 312.5 pg of DNA was necessary for genotype determination, but after preamplification of DNA from FFPE specimens, genotype could be established from as little as 9.8 pg of DNA. After preamplification of FFPE specimens, a call rate of 84-100% was achieved using TaqMan assays. In 8 patients, there was 100% concordance of genotype and copy number variation as determined from fresh blood and preamplified FFPE specimens. In contrast, 4 of 22 genotypes were not concordant when results from non-preamplified FFPE specimens were compared to those from fresh blood specimens.

Studies

  1. Study Purpose

    The purpose of this study was to compare genotypes and call rates from FFPE breast carcinomas and fresh blood specimens and to determine the effect of preamplification of FFPE specimens.

    Summary of Findings:

    In non-preamplified FFPE specimens, 312.5 pg of DNA was necessary for genotype determination, but after preamplification of DNA from FFPE specimens, genotype could be established from as little as 9.8 pg of DNA. After preamplification of FFPE specimens, a call rate of 84-100% was achieved using TaqMan assays. In 8 patients, there was 100% concordance of genotype and copy number variation as determined from fresh blood and preamplified FFPE specimens. In contrast, 4 of 22 genotypes were not concordant when results from non-preamplified FFPE specimens were compared to those from fresh blood specimens.

    Biospecimens
    Preservative Types
    • Formalin
    • None (Fresh)
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    DNA SNP assay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Biospecimen location Blood
    Breast
    Biospecimen Preservation Type of fixation/preservation Formalin (buffered)
    None (fresh)
    Biospecimen Acquisition Anticoagulant EDTA
    SNP assay Specific Nucleic acid amplification Preamplified FFPE specimen
    Not amplified FFPE specimen
    Not amplified fresh blood specimen

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...